InsiderTrades

Form 4 for CNMD CONMED Corp

Accepted 2021-08-30 00:00:00 ET · period of report 2021-08-27 · accession 0001127602-21-024541 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2021-08-30 2021-08-27 CNMD KENNEDY JOHN JED Group EVP M - OptEx $40.06 +5,438 7,873 +223% +$217.8K
DM 2021-08-30 2021-08-27 CNMD KENNEDY JOHN JED Group EVP S - Sale+OE $134.78 -5,438 7,375 -42% -$732.9K
DM 2021-08-30 2021-08-27 CNMD KENNEDY JOHN JED Group EVP M - OptEx $0.00 -5,438 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2021-08-27 M A 4,940 $39.87 12,315 D — —
2 Common Common Stock 2021-08-27 M A 498 $41.93 7,873 D — —
3 Common Common Stock 2021-08-27 S D 498 $134.75 7,375 D — —
4 Common Common Stock 2021-08-27 S D 4,940 $134.78 7,375 D — — (F1) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $134.75 to $135.05. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
5 Derivative Options To Purchase Common Stock 2021-08-27 M D 498 $0.00 9,502 D $41.93 · — to 2027-03-01 498 Common Stock (F2) The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.
6 Derivative Options To Purchase Common Stock 2021-08-27 M D 4,940 $0.00 0 D $39.87 · — to 2026-03-01 4,940 Common Stock (F2) The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.